CAUSES OF KIDNEY ALLOGRAFT LOSS IN A LARGE PEDIATRIC POPULATION AT A SINGLE-CENTER

被引:26
作者
CHAVERS, BM
KIM, EM
MATAS, AJ
GILLINGHAM, KJ
NAJARIAN, JS
MAUER, SM
机构
[1] Department of Pediatrics, University of Minnesota, 13-240 Moos Tower, Minneapolis, 55455, MN
[2] Department of Surgery, University of Minnesota, 13-240 Moos Tower, Minneapolis, 55455, MN
关键词
ALLOGRAFT LOSS; CAUSES; LARGE SINGLE-CENTER PEDIATRIC POPULATION;
D O I
10.1007/BF00868263
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
At our institution, 521 kidney transplants were performed in 429 children (mean age 8.7 +/- 5.6-years) between 1969 and 1991. Of these transplants, 408 were primary, 113 were retransplants, 347 were living related, 171 were cadaver, and 3 were living nonrelated. Immunosuppression consisted of prednisone, azathioprine, and Minnesota antilymphocyte globulin (non-CSA) in 339 patients, total lymphoid irradiation in 8, and, more recently, cyclesporine (CSA) in addition in 168 patients. Average followup was 8.8 +/- 6.0 years. Actuarial graft survival in the non-CSA versus CSA groups at 1 year was 77.0% versus 85.7%; at 5- years, 59.6% versus 71.9%. Of 136 non-CSA patients, causes of graft loss at 5 years included: chronic rejection in 55 (40.4%), acute rejection in 27 (19.9%), recurrent disease in 16 (11.8%), technical complications in 8 (5.9%), infectious complications in 4 (2.9%), other causes in 5 (3.7%), and death with a functioning graft in 21 (15.4%). Of 40 CSA patients, causes of graft loss at 5 years included: chronic rejection in 16 (40.0%), acute rejection in 8 (20.0%), recurrent disease in 6 (15.0%), technical complications in 3 (7.5%), other causes in 2 (5.0%), and death with a functioning graft in 5 (12.5%). The causes of graft loss did not significantly differ in the non-CSA and CSA groups. Chronic rejection was the most common cause of graft loss in both groups. Research focusing on chronic rejection is needed to improve graft outcome in pediatric kidney transplantation.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 32 条
  • [11] Offner G., Hoyer P.F., Brodehl J., Pichlmayr R., Cyclosporine A in pediatric kidney transplantation, Pediatr Nephrol, 1, pp. 125-130, (1987)
  • [12] Alexander S.R., Arbus G.S., Butt K.M.H., Conley S., Fine R.N., Greifer I., Gruskin A.B., Harmon W.E., McEnery P.T., Nevins T.E., Nogueira N., Salvatierra O., Tejani A., The 1989 report of the North American Pediatric Renal Transplant Cooperative Study, Pediatr Nephrol, 4, pp. 542-553, (1990)
  • [13] Ettenger R.B., Rosenthal J.T., Marik J., Nelson P., Malekzadeh M., Grimm P.C., Kamil E.S., Salusky I.B., Fine R.N., Cadaver renal transplantation in children: results with long-term cyclosporine immunosuppression, Clin Transplant, 4, pp. 329-336, (1990)
  • [14] Schweitzer E.J., Matas A.J., Gillingham K.J., Payne W.D., Gores P.F., Dunn D.L., Sutherland D.E.R., Najarian J.S., Causes of renal allograft loss: progress in the 1980s, challenges for the 1990s, Ann Surg, 214, pp. 679-688, (1991)
  • [15] Gruber S.A., Chavers B., Skjei K.L., Sothern R.B., Robison L., Tzardis P., Moss A., Gillingham K., Canafax D.M., Najarian J.S., Matas A.J., Dun D.L., De novo cancer after pediatric kidney transplantation, Transplant Proc, 23, pp. 1373-1374, (1991)
  • [16] Penn I., Occurrence of cancers in immunosuppressed organ transplant recipients, Clinical transplants 1990, pp. 53-62, (1991)
  • [17] Melosky B., Karim M., Chui A., McBride M., Cameron E.C., Yeung C.K., Landsberg D., Shackleton C., Keown P.A., Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression, J Am Soc Nephrol, 2, pp. S290-S294, (1992)
  • [18] Broyer M., Kidney transplantation in children — data from the EDTA Registry, Transplant Proc, 21, pp. 1985-1988, (1989)
  • [19] Broyer M., Selwool N., Brunner F., Recurrence of primary renal disease on kidney graft: a European pediatric experience, J Am Soc Nephrol, 2, pp. S255-S257, (1992)
  • [20] McEnery P.T., Stablein D.M., Arbus G., Tejani A., Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study, N Engl J Med, 326, pp. 1727-1732, (1992)